If you have tried these medications to prevent migraines—without
significant
improvement—you may be eligible for a new clinical research trial called
ESCAPE. The trial may help uncover a new answer for migraine sufferers.
ESCAPE (Effect of Septal Closure of Atrial PFO on Events of Migraine with
Premere™) is a new clinical trial that studies the link between a
heart condition called PFO and the incidence of migraines. PFO, or patent
foramen ovale, is a heart defect that forms when a small hole between the right
and left upper chambers of the heart (atria) don' t close in infancy. About 25%
of all adults may have PFO, but for most people it does not cause serious
health problems.
There may be a cause-effect relationship
between your migraines and PFO
Several clinical experiences have shown a possible link between PFOs and
migraines. Several doctors have reported that closing a PFO in patients with
migraine headaches and a previous stroke has reduced the frequency and
intensity of migraines.
Find out if you or someone you know may be a candidate for this trial. Complete the self-assessment survey.
View the ESCAPE brochure
for additional information you and your physician can discuss.
Note: You'll need Adobe Acrobat® Reader to view and print PDF files.
Get Adobe Acrobat® Reader. Follow the instructions provided.
